COVID-19疫情期间单侧突发性听力下降患者的远程医疗模型
该前瞻性队列研究在2020年5月至2021年1月纳入51例新发单侧突发性听力下降成人患者,评估由Hum Test韦伯试验和uHear应用测听组成的远程医疗模型。模型识别符合突发性感音神经性听力下降听力学标准(≥3个连续频率损失≥30 dB)的敏感度为100%(95%CI 84%-100%),特异度为73%(95%CI 54%-88%),准确率为84.3%(95%CI 71%-93%)。作者认为该模型有效可靠,可作为初级分诊工具。
要点
- 远程医疗模型敏感度100%(95%CI 84%-100%),特异度73%(95%CI 54%-88%)。
- 阳性预测值72%(95%CI 53%-87%),阴性预测值100%(95%CI 85%-100%)。
- 8例假阳性者均为未完全符合听力学标准的突发性感音神经性听力下降。
核心结论
- 该远程医疗模型用于诊断突发性感音神经性听力下降有效且可靠,可作为区分需紧急治疗患者与非需紧急治疗患者的初级工具,尤其在COVID-19疫情期间。
研究设计与样本
- 前瞻性队列研究,于2020年5月至2021年1月在一家三级转诊医疗中心开展,判读医师对正式听力图结果设盲。
- 连续纳入51例因新发单侧突发性听力下降至耳鼻咽喉科急诊就诊的成人患者(年龄≥18岁;中位年龄45岁,范围18-76岁;男性28例,占54.9%)。
- 远程医疗模型包括两个序贯步骤:使用Hum Test和智能手机振动的韦伯试验,以及基于uHear应用的测听。
主要发现
- 远程医疗模型满足突发性感音神经性听力下降听力学标准(≥3个连续频率损失≥30 dB)的敏感度为100%(95%CI 84%-100%),特异度为73%(95%CI 54%-88%)。
- 阳性预测值为72%(95%CI 53%-87%),阴性预测值为100%(95%CI 85%-100%),准确率为84.3%(95%CI 71%-93%)。
- 8例参与者出现假阳性结果,但所有假阳性者均为未完全符合听力学标准的突发性感音神经性听力下降。
关键数值与推荐
- 突发性感音神经性听力下降的听力学标准为≥3个连续频率损失≥30 dB。
临床怎么用
- 作者认为该远程医疗模型可作为初级工具,用于区分需紧急治疗的突发性感音神经性听力下降患者与非需紧急治疗患者,尤其在COVID-19疫情期间。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Developing a telemedicine tool to discriminate between patients who need urgent treatment for sudden sensorineural hearing loss (SSNHL) from those who do not takes on special importance during the COVID-19 pandemic. OBJECTIVE: To explore the feasibility of a telemedicine model to assist in the evaluation of new-onset unilateral sudden hearing loss (SHL) among patients who do not have access to medical resources, especially during the COVID-19 pandemic. DESIGN, SETTING, AND PARTICIPANTS: This prospective cohort investigation of a telemedicine model was conducted at a tertiary referral medical center between May 2020 and January 2021, with the interpreting physician blinded to the results of formal audiograms. The study included a consecutive sample of adult patients (aged ≥18 years) referred to the otolaryngology emergency department in our medical center with the chief complaint of new-onset unilateral SHL. INTERVENTIONS: The telemedicine model comprised 2 sequential steps: a Weber test using the Hum Test and a smartphone-based vibration, and uHear app-based audiometry. MAIN OUTCOMES AND MEASURES: Discrimination between patients with and without SSNHL by using the telemedicine model. All diagnoses subsequently confirmed by a formal audiogram. RESULTS: Fifty-one patients with new-onset unilateral SHL participated in the study study (median age, 45 [range, 18-76] years; 28 [54.9%] men). The sensitivity and specificity of the telemedicine model for fulfilling the audiometric criteria of SSNHL (loss of ≥30 dB in ≥3 consecutive frequencies) were 100% (95% CI, 84%-100%) and 73% (95% CI, 54%-88%), respectively. The PPV was 72% (95% CI, 53%-87%), the NPV was 100% (95% CI, 85%-100%), and the accuracy was 84.3% (95% CI, 71%-93%). Although 8 participants had false-positive results, all of them had SSNHL that did not meet the full audiometric criteria. CONCLUSIONS AND RELEVANCE: The telemedicine model presented in this study for the diagnosis of SSNHL is valid and reliable. It may serve as a primary tool for the discrimination between patients in need of urgent care for SSNHL from those who are not, especially during the COVID-19 pandemic.
引用
- Shilo S, Ungar OJ, Handzel O, et al. Telemedicine for Patients With Unilateral Sudden Hearing Loss in the COVID-19 Era. JAMA Otolaryngol Head Neck Surg. 2022. PMID: 34940804. doi:10.1001/jamaoto.2021.3672
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。